Key features in the clinical examination of interstitial lung diseases and their management are the focus of a new clinical review. Highlights here.
Wallis A, Spinks K. Clinical Review: The diagnosis and management of interstitial lung diseases. BMJ 2015;350:h2072 doi: 10.1136/bmj.h2072 (7 May 2015)
Interstitial lung disease is an involvement of rheumatic disease, and an adverse effect of methotrexate, leflunamide, sulphasalazine, penicillamine, and anti-tumor necrosis factor agents.
This is a quick clinical review, emphasizing diagnosis.
Key features in the clinical examination are:
• Bi-basal end inspiratory crepitations
• Inspiratory squeaks
• Finger clubbing
• Pleural effusion
• Pulmonary hypertension
• Skin signs of scleroderma
• Lymphadenopathy and hepatosplenomegaly
• Neurological findings
• Ocular signs